- Drugs
- Friday, 20 Sep 2019
Aurora Cannabis and UFC Launch Clinical Research on Use of Hemp-Derived CBD Products by MMA Athletes
Aurora Cannabis Inc. and UFC, the world's premier mixed martial arts organization, announced the launch of a joint clinical research program that will produce multiple studies under the terms of their recently announced partnership. Aurora Cannabis Inc. the Canadian company defining the future of cannabis worldwide, announced that it has received Health Canada licenses for outdoor cultivation at two Canadian sites.
Aurora Cannabis Inc. and EnWave Corporation entered into a royalty-bearing commercial license agreement providing Aurora with the exclusive rights to EnWave's patented Radiant Energy Vacuum (REVTM) drying technology for the production of cannabis materials in the European Union, excluding Portugal.
Aurora Cannabis, Inc. is a Canada-based company, which is engaged in the production and distribution of medical cannabis. It also produces and sells indoor cultivation systems and hemp related food products. Through state-of-the-art production facilities and exclusive sales agreements in the European Union and beyond, the company operates around the globe pursuing new and emerging cannabis markets. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
Aurora Cannabis is expanding its network of subsidiaries and partnerships that offers strategic differentiation through its broad global reach, high-tech, low-cost production facilities, unique product offerings and science driven innovations across the entire cannabis value chain. Aurora is rapidly developing its assets and capabilities in the emerging CBD-based wellness market. With extensive hemp assets across Canada, Latin America and Europe, combined with an industry-leading product development team and deep brand building capabilities, the Company is well positioned to pursue a leading role in this rapidly developing segment.
Related Industry Updates
Generic Oncology Drugs Market Size to Grow with Stupendous CAGR of 6.3% from Forecasts 2019 – 2027 | Zydus Cadila, Glenmark, Aurobindo Pharma
Feb 11, 2021
Biotin Supplements Market Pegged for Robust Expansion by 2027
Dec 12, 2020
Cannabis Market is expected to reach US$ 1,99,504.9 million by 2028
Jan 31, 2023
Stomach Cancer Market is expected to reach US$ 10,751.42 million by 2030
Dec 28, 2023
South & Central America Gastrointestinal Drugs Market: Business Growth, Development Factors, Applications, and Future Prospects
Dec 15, 2020
RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress
Mar 26, 2020
Canna Hemp and The Growing Demand for Quality CBD Wellness Products
Mar 20, 2020